ASTH
Astrana Health Inc
NASDAQ: ASTH · HEALTHCARE · MEDICAL CARE FACILITIES
$37.98
-0.13% today
Updated 2026-09-11
Market cap
$1.89B
P/E ratio
46.41
P/S ratio
0.49x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$18 – $52
Volume
0.5M
WallStSmart proprietary scores
56
out of 100
Grade: C+
Hold
Investment rating
10.0
Growth
A+4.5
Quality
C4.5
Profitability
C4.7
Valuation
C1/9
Piotroski F-Score
Weak
2.1
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$51.50
+35.60%
12-Month target
$11.04
-70.93%
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $92.93M — positive
+ Revenue growth 48.50% QoQ
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at 1.06%
- P/E 46.41x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.14B | $1.39B | $2.03B | $3.18B | $3.84B |
| Net income | $45.17M | $60.72M | $43.15M | $22.49M | $19.74M |
| EPS | — | — | — | — | $0.82 |
| Free cash flow | $59.19M | $39.70M | $44.17M | $104.49M | $92.93M |
| Profit margin | 3.95% | 4.38% | 2.12% | 0.71% | 1.06% |
Peer comparison
Smart narrative
Astrana Health Inc trades at $37.98. representing a P/E of 46.41x trailing earnings. Our Smart Value Score of 56/100 indicates the stock is fair. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 2.10, it sits in the grey zone. TTM revenue stands at $3.84B. with profit margins at 1.06%.
Frequently asked questions
What is Astrana Health Inc's stock price?
Astrana Health Inc (ASTH) trades at $37.98, on a P/E of 46.4x and a P/S of 0.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Astrana Health Inc overvalued?
Astrana Health Inc carries a Smart Value Score of 56/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Astrana Health Inc (ASTH)?
The 12-month analyst consensus target is $51.50, about 35.6% above the current $37.98. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Astrana Health Inc's revenue?
Astrana Health Inc's trailing twelve-month revenue is $3.84B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Astrana Health Inc's Altman Z-Score is 2.10, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.49x
ROE3.78%
Beta0.91
50D MA$40.59
200D MA$31.53
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—